Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
A major trial of inhaled treprostinil for lung fibrosis has finished enrolling patients
-
A trial of inhaled treprostinil for lung fibrosis has finished enrolling patients
-
The kidney society council election deadline is approaching
A trial of inhaled treprostinil for pulmonary fibrosis (scarring in lungs) has finished enrolling 754 patients. Results are expected in late 2027.
Arterial Stiffness in Children and Young People With Hypertension and Chronic Kidney Disease
This trial looks at arterial stiffness (hardening of arteries) in children and young people with kidney disease. Arterial stiffness is a marker for cardiovascular risk, but this study's results are not yet available.
Impact of Acute Kidney Injury on Hospitalization Outcomes in Patients with Chronic Kidney Disease Undergoing Cardiac Procedures with Cardiopulmonary Bypass in the United States.
Acute kidney injury (AKI) after cardiac surgery may cause permanent damage. This study looks at risk in patients with pre-existing kidney disease.
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
This is an extension study for patients who completed a previous trial of zigakibart. It will monitor long-term safety in adults with IgA nephropathy.
Nephrocalcinosis Following Roux-en-Y Gastric Bypass Secondary to Suspected Enteric Hyperoxaluria: A Case Report.
Gastric bypass surgery may lead to calcium oxalate deposits in the kidney. This case report discusses risk factors for this condition.